Vista Finance LLC purchased a new position in Balchem Co. (NASDAQ:BCPC – Free Report) in the fourth quarter, Holdings Channel.com reports. The firm purchased 1,259 shares of the basic materials company’s stock, valued at approximately $205,000.
A number of other institutional investors and hedge funds have also bought and sold shares of the business. Congress Asset Management Co. raised its stake in Balchem by 5.4% during the 4th quarter. Congress Asset Management Co. now owns 317,610 shares of the basic materials company’s stock valued at $51,769,000 after purchasing an additional 16,170 shares during the period. Van ECK Associates Corp raised its position in shares of Balchem by 4.8% during the fourth quarter. Van ECK Associates Corp now owns 67,362 shares of the basic materials company’s stock valued at $10,980,000 after buying an additional 3,110 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in shares of Balchem by 2.0% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 92,796 shares of the basic materials company’s stock worth $15,125,000 after buying an additional 1,822 shares in the last quarter. Entropy Technologies LP bought a new position in shares of Balchem during the fourth quarter worth $689,000. Finally, Apollon Wealth Management LLC purchased a new position in Balchem during the fourth quarter valued at $503,000. 87.91% of the stock is owned by institutional investors.
Balchem Price Performance
BCPC stock opened at $164.82 on Friday. Balchem Co. has a 52 week low of $137.69 and a 52 week high of $186.03. The firm has a market capitalization of $5.36 billion, a P/E ratio of 44.31, a price-to-earnings-growth ratio of 4.42 and a beta of 0.69. The company has a fifty day simple moving average of $163.46 and a two-hundred day simple moving average of $169.59. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21.
Balchem Increases Dividend
Analysts Set New Price Targets
Several analysts have commented on BCPC shares. StockNews.com upgraded shares of Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th. HC Wainwright raised their price target on Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a report on Monday, November 4th.
Check Out Our Latest Stock Report on Balchem
About Balchem
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Featured Articles
- Five stocks we like better than Balchem
- How to Use Stock Screeners to Find Stocks
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- How to Profit From Growth Investing
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- How to Capture the Benefits of Dividend Increases
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Free Report).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.